Nicolas Beuzen

Nicolas Beuzen serves as the Director of Drug Development and Strategic Innovation Partnerships at Adamed Pharma since March 2025, following a role as an Investment Professional at i&i Biotech Fund from January 2024 to March 2025. Previously, Nicolas held the position of Director of Business Development & Licensing at Molecure from 2016 to 2023, where responsibilities included deal structuring, negotiation, and financial analysis. As the founder of MMKB Life Science, Nicolas provided consultancy in preclinical R&D across central and eastern Europe. Earlier positions include VP Development and Chief Scientific Officer at Selvita, where significant contributions involved developing R&D strategies and managing high-value partnerships. Additional experience includes project management roles at Ethypharm and EUSA Pharma, along with consultancy at Michael Page. Nicolas holds a PhD in Molecular Biology from the University of Glasgow and a Master of Science in Pharmaceutical Marketing and Management from iaelyon School of Management.